Spironolactone-furosemide combination therapy and acid-base disorders in liver cirrhosis patientsâ©. | Int J Clin Pharmacol Ther;58(5): 261-267, 2020 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Spironolactone-furosemide combination therapy and acid-base disorders in liver cirrhosis patientsâ©.

Gottfriedová, Halima; Lánská, Vera; Jabor, Antonín; Cáslavská, Milena; Spicák, Julius; Horácková, Miroslava; Schück, Otto.

Int J Clin Pharmacol Ther ; 58(5): 261-267, 2020 May.

Article in En | MEDLINE | ID: mdl-32213284

Subject(s)

Acid-Base Imbalance/complications; Diuretics/therapeutic use; Furosemide/therapeutic use; Liver Cirrhosis/therapy; Spironolactone/therapeutic use; Drug Therapy, Combination; Humans; Liver Cirrhosis/complications

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Acid-Base Imbalance / Diuretics / Furosemide / Liver Cirrhosis Limits: Humans Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Acid-Base Imbalance / Diuretics / Furosemide / Liver Cirrhosis Limits: Humans Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Type: Article